Work

Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis

Year: 2023

Type: article

Abstract: Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis

Source: Haematologica

DOI: 10.3324/haematol.2022.282089

Authors: Claire Harrison, Abdulraheem Yacoub, Bart Scott, Adam Mead, Aaron T. Gerds, Jean-Jacques Kiladjian, Ruben Mesa, Miklos Egyed, Christof Scheid, Valentin Garcia Gutierrez, Jennifer O’Sullivan, Sarah Buckley, Kris Kanellopoulos, John Mascarenhas

Institutions: Guy's and St Thomas' NHS Foundation Trust, The University of Kansas Cancer Center, Fred Hutch Cancer Center, University of Oxford, Cleveland Clinic, Université Paris Cité, Hôpital Saint-Louis, Mays Cancer Center at UT Health San Antonio, Somogy Megyei Kaposi Mór Oktató Kórház, University Hospital Cologne, Instituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón y Cajal, CTI BioPharma (United States), Icahn School of Medicine at Mount Sinai

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funders: CTI Biopharma, Cancer Research UK, National Cancer Institute

Awards: G3932060010, G4851334175, G6648058116, Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients

OpenAlex ID: W4313545299

FWCI: 0.345

Cites: 11

Cited by: 2

Related to: 10